S. Korea makes final check on vaccine deployment plan in mock drill
时间:2024-09-21 19:27:55 来源:摩登家庭人人影视网 作者:产品中心 阅读:968次
Earlier this month, health authorities and related agencies conducted the first mock drill at Incheon International Airport, west of Seoul, for the transport of the foreign-made Pfizer COVID-19 vaccine.
Friday's second and final rehearsal focused on transporting the AstraZeneca's vaccine, to be produced at a SK Bioscience Co. factory in the southeastern city of Andong, to a distribution center in Icheon, south of Seoul, and then to 25 local health centers across the nation.
To be fully prepared for any emergency situations, the authorities mobilized the Air Force's C-130 cargo plane and helicopters to rehearse their delivery to islands, such as Jeju and Ulleung Islands, according to the defense ministry.
"Basically, the ground transport will be used for their delivery from the factory to the distribution center. To send them to islands, either vessels, helicopters or military transport aircraft will be mobilized in accordance with weather conditions and other circumstances," a ministry official said.
The defense ministry launched a vaccine distribution task force last month, which is in charge of managing the transportation and distribution of COVID-19 vaccines, in cooperation with the Korea Disease Control and Prevention Agency (KDCA), the National Police Agency and other related entities.
"This drill was to simulate the whole procedure of the vaccine distribution plan by fully adhering to due rules," the defense ministry said in a release. "Not only government agencies but civilian experts joined the drill to ensure perfection in the overall delivery system."
South Korea plans to administer its first inoculations against the new coronavirus on Feb. 26, with AstraZeneca's vaccines, for those aged younger than 65.
So far, the government has secured vaccines for 79 million, more than the nation's population, through deals with the World Health Organization's global vaccine COVAX Facility project and separate contracts with foreign drug firms. (Yonhap)
(责任编辑:新闻中心)
最新内容
- ·采购商+48,英德红茶在泉城济南蹭蹭涨粉
- ·The coolest (and silliest) wearables that don’t go on your wrist
- ·Watch Ivanka Trump awkwardly try to converse with world leaders at G20
- ·Samsung's upcoming Galaxy S20 line leaked in full detail
- ·22 Unusual Things You Can Find in the Desert
- ·The polar vortex has been disrupted. What does that bode?
- ·NK leader calls for stronger military power in photo session with parade participants
- ·YouTube’s new 'made for kids' content rules are a good first step
- ·7 Reasons to Explore Boston’s Lesser
- ·S. Korean, US intelligence agencies issue joint security advisory against NK cyber threat
热点内容
- ·Slot extends perfect Liverpool start
- ·Luis Bracamontes isn’t the villain in Trump’s immigration ad.
- ·So Ivanka Trump's big idea for 'the future of work' is ... LinkedIn?
- ·Sophie Turner and Joe Jonas' official wedding photo is as glamorous as you'd expect
- ·The Best AMD Ryzen Gaming Laptops (So Far)
- ·A viral anti
- ·The best Pride Month memes of 2019
- ·On Fox News, Donald Trump won the midterms.
- ·Students get free entry at second Rawalpindi Test but what’s the catch?
- ·Nancy Pelosi labels Facebook as 'accomplices' in misleading Americans